There is no Press for this Ticker
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Outlook Therapeutics, Inc. - Series A Warrant Questions & Anwsers

Q

How do I buy Outlook Therapeutics, Inc. - Series A Warrant (OTLKW) stock?

A

You can purchase shares of Outlook Therapeutics, Inc. - Series A Warrant (NASDAQ: OTLKW) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics, Inc. - Series A Warrant's (OTLKW) competitors?

A

There are no as such competitors for Outlook Therapeutics, Inc. - Series A Warrant.

Q

What is the target price for Outlook Therapeutics, Inc. - Series A Warrant (OTLKW) stock?

A

There is no analysis for Outlook Therapeutics, Inc. - Series A Warrant

Q

Current Stock Price for Outlook Therapeutics, Inc. - Series A Warrant (OTLKW)?

A

The stock price for Outlook Therapeutics, Inc. - Series A Warrant (NASDAQ: OTLKW) is $0.05 last updated Fri Jan 14 2022 20:54:30 GMT+0000 (Coordinated Universal Time).

Q

Does Outlook Therapeutics, Inc. - Series A Warrant (OTLKW) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics, Inc. - Series A Warrant.

Q

When is Outlook Therapeutics, Inc. - Series A Warrant (NASDAQ:OTLKW) reporting earnings?

A

Outlook Therapeutics, Inc. - Series A Warrant does not have any upcoming earnings scheduled.

Q

Is Outlook Therapeutics, Inc. - Series A Warrant (OTLKW) going to split?

A

There is no upcoming split for Outlook Therapeutics, Inc. - Series A Warrant.

Q

What sector and industry does Outlook Therapeutics, Inc. - Series A Warrant (OTLKW) operate in?

A

Outlook Therapeutics, Inc. - Series A Warrant is in the sector and industry. They are listed on the NASDAQ.